Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Nature Medicine

Volumn 6, Issue 1, 2000, Pages 96-99

  Higashitsuji, Hiroaki ^a   Itoh, Katsuhiko ^a   Nagao, Toshikazu ^a   Dawson, Simon ^b   Nonoguchi, Kohsuke ^a   Kido, Tsuneo ^a   Mayer, R John ^b   Arii, Shigeki ^a   Fujita, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

3T3 CELLS; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CLONING, MOLECULAR; GENES, REPORTER; GENES, RETINOBLASTOMA; HELA CELLS; HUMANS; KINETICS; LIVER; LIVER NEOPLASMS; MICE; MICE, NUDE; ONCOGENE PROTEINS; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033978257     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71600     Document Type: Article

References (20)

1. Hsu, I.C. et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428 (1991).
2. Bressac, B., Kew, M., Wands, J. & Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429-431 (1991).
3. INK4A gene alterations in hepatocellular carcinoma. Oncogene 18, 789-795 (1999).
4. Higuchi, T. et al. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology 136, 4973-4981 (1995).
5. Hori, T. et al. cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 216, 113-122 (1998).
6. Dawson, S. et al. The 26S-proteasome: regulation and substrate recognition. Mol. Biol. Rep. 24, 39-44 (1997).
7. Nevins, J.R., Leone, G., DeGregori, J. & Jakoi, L. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173, 233-236 (1997).
8. Weinberg, R.A. the retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
9. Chen, Y., Sharp, Z.D. & Lee, W.H. HEC binds to the seventh regulatory subunitof the 26S proteasome and modulates the proteolysis of mitotic cyclins. J. Biol. Chem. 272, 24081-24087 (1997).
10. Mahaffey, D. & Rechsteiner, M. Discrimination between ubiquitin-dependent and ubiquitm-independent proteolytic pathways by the 26S proteasome subunit 5a. FEBS Lett. 450, 123-125 (1999).
11. Kisselev, A.F., Akopian, T., Woo, K.M. & Goldberg, A.L. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274, 3363-3371 (1999).
12. Woitach, J.T., Zhang, M., Niu, C.H. & Thorgeirsson, S.S. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nature Genet. 19, 371-374 (1998).
13. Johnson, D.G., Schneider-Broussard, R. Role of E2F in cell cycle control and cancer. Front. Biosci. 3, d447-448 (1998).
14. Israel, A. IkB kinase all zipped up. Nature 388, 519-521 (1997).
15. Ciechanover, A. et al. The ubiquitin-mediated proteolytic system: involvement of molecular chaperones, degradation of oncoproteins, and activation of transcriptional regulators. Cold Spring Harb. Symp. Quant. Biol. 60, 491-501 (1995).
16. Spataro, V., Norbury, C. & Harris, A.L. The ubiquitin-proteasome pathway in cancer. Br. J. Cancer 77, 448-455 (1998).
17. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. & Howley, P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993).
18. Boyer, S.N., Wazer, D.E. & Band, V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56, 4620-4624 (1996).
19. Berezutskaya, E. & Bagchi, S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J. Biol. Chem. 272, 30135-30140 (1997).
20. Smith-McCune, K. et al. Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130. Proc. Natl. Acad. Sci. USA 96, 6999-7004 (1999).